Cargando…

A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia

BACKGROUND: Deep vein thrombosis and pulmonary embolism are known by the collective name venous thromboembolism. Deep vein thrombosis is the third most common cardiovascular disorder in the world. The disease is also prevalent in Africa including Ethiopia, besides lack of studies that show epidemiol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derseh, Manaye Tamrie, Solomon, Kiflom, Tamene, Wasihun, Beneberu, Wosenie, Yayehrad, Ashagrachew Tewabe, Ambaye, Abyou Seyfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453646/ https://www.ncbi.nlm.nih.gov/pubmed/34557006 http://dx.doi.org/10.2147/CEOR.S327868

Ejemplares similares

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2021)

Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2021)

Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
por: Tewabe, Ashagrachew, et al.
Publicado: (2021)

Genetics InFormatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT): Rationale and Study Design
por: Do, Elizabeth J., et al.
Publicado: (2011)

Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2022)

How Combined Macrolide Nanomaterials are Effective Against Resistant Pathogens? A Comprehensive Review of the Literature
por: Siraj, Ebrahim Abdela, et al.
Publicado: (2023)

3D printed drug loaded nanomaterials for wound healing applications
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2023)

Physicochemical Characterization and Evaluation of Ficus vasta Gum as a Binder in Tablet Formulation
por: Yayehrad, Ashagrachew Tewabe, et al.
Publicado: (2023)

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
por: Wang, Yuqi, et al.
Publicado: (2013)

The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019)

Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study
por: Khorvash, Fariborz, et al.
Publicado: (2021)

Point-of-care ultrasound in patients with suspected deep vein thrombosis (DVT)
por: Al hashimy, Mohammad, et al.
Publicado: (2013)

Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China
por: Yang, Li, et al.
Publicado: (2020)

Balantidium coli; Rare and Accidental Finding in the Urine of Pregnant Woman: Case Report
por: Almaw, Andargachew, et al.
Publicado: (2022)

Incidence of Deep Vein Thrombosis (DVT) in Patients Using A Knee Scooter
por: Davidson, Stuart, et al.
Publicado: (2022)

Deep Vein Thrombosis (DVT) Prophylactic Team Activity to Support DVT Prevention Protocol for the Purpose of the Prophylaxis of Pulmonary Thromboembolism (PTE) and Operation
por: Tamura, Shozo, et al.
Publicado: (2021)

Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report
por: Schiavoni, Mario, et al.
Publicado: (2016)

Warfarin-induced deep vein thrombosis
por: Binymin, Khalid A, et al.
Publicado: (2014)

Self-Medication Prevalence and Factors Associated with Knowledge and Attitude Towards Self-Medication Among Undergraduate Health Science Students at GAMBY Medical and Business College, Bahir Dar, Ethiopia
por: Siraj, Ebrahim Abdela, et al.
Publicado: (2022)

Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis
por: Cheng, Gregory, et al.
Publicado: (2011)

Air pollution and hospital admissions due to deep vein thrombosis (DVT) in Ahvaz, Iran
por: Borsi, Seyed Hamid, et al.
Publicado: (2020)

Functional Neurological Symptom Disorder (FND) Leading to the Development of Deep Vein Thrombosis (DVT)
por: Othman, Ahmad, et al.
Publicado: (2022)

Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency
por: Ameku, Koken, et al.
Publicado: (2018)

Study on the Risk Factors of Preoperative Deep Vein Thrombosis (DVT) in Patients With Lower Extremity Fracture
por: Chang, Wenjie, et al.
Publicado: (2021)

Bilateral Deep Vein Thrombosis (DVT) as a Harbinger of Lung Adenocarcinoma: A Rare Presentation
por: Ba-shammakh, Saleh A, et al.
Publicado: (2023)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Warfarin associated venous limb gangrene in cancer-related DVT (case report)
por: Cojocari, Vladimir, et al.
Publicado: (2017)

Development and validation of a predictive nomogram for preoperative deep vein thrombosis (DVT) in isolated calcaneal fracture
por: Cheng, Xinqun, et al.
Publicado: (2022)

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
por: Yamada, Norikazu, et al.
Publicado: (2015)

Computational Analysis of the Related Factors of Deep Vein Thrombosis (DVT) Formation in Patients Undergoing Hip Fracture Surgery
por: Zhou, Yi, et al.
Publicado: (2022)

The Correlation Between Preoperative Lower Extremity Deep Vein Thrombosis (DVT) and the Time from Injury to Surgery (TFITS)
por: Cong, Yuxuan, et al.
Publicado: (2022)

May-Thurner syndrome: A case of extensive unprovoked left lower extremity deep vein thrombosis (DVT)
por: Akinleye, Akintayo, et al.
Publicado: (2023)

Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban
por: Piati, Polyana Klomfass, et al.
Publicado: (2019)

Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’
por: Yamada, Norikazu, et al.
Publicado: (2016)

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
por: Yang, Hyeyoung, et al.
Publicado: (2016)

Hemorrhagic Cholecystitis after Warfarin Use for Deep Vein Thrombosis
por: Donn, Eric, et al.
Publicado: (2018)

A Retrospective cohort study on the risk factors of deep vein thrombosis (DVT) for patients with traumatic fracture at Honghui Hospital
por: Zhang, Wenjuan, et al.
Publicado: (2019)

Retracted: Computational Analysis of the Related Factors of Deep Vein Thrombosis (DVT) Formation in Patients Undergoing Hip Fracture Surgery
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy
por: Hartmann, Sonja, et al.
Publicado: (2020)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
por: Stolz, Leonie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_celpui41ih3ebq1ie1l3fh4dkm